Red Arrow Therapeutics - Crunchbase Company Profile & Funding

Q: Where is Red Arrow Therapeutics's headquarters?

Red Arrow Therapeutics is located in Minato, Chiba, Japan.

Q: Who invested in Red Arrow Therapeutics?

Red Arrow Therapeutics has 11 investors including Axil Capital And Boxer Capital.

Q: How much funding has Red Arrow Therapeutics raised to date?

Red Arrow Therapeutics has raised obfuscated.

Overview

Red Arrow Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Red Arrow Therapeutics

CB Rank

39199

Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

Founded

obfuscation

Private

Series A

Minato, Chiba, Japan

11-50

redarrowtx.com

Alternative Medicine

Biotechnology

Product Research

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Non-equity Assistance

OBF

obfuscation

Key People

Takuya Miyazaki: Founder & CEO
Horacio Cabral: Co-Founder & Drug Discovery Head (Scientific Advisor)

Details

Legal Name

Red Arrow Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Horacio Cabral, Takuya Miyazaki

Phone Number

+81 80-1785-6939

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RA001

A pH-sensitive polymeric micelle formulation delivering interleukin-12 (IL-12) to tumors to activate immune response against cancer cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A
obfuscated obfuscation	Series A - Red Arrow Therapeutics	5	obfuscated obfuscation	Third Rock Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Axil Capital	—	Series A - Red Arrow Therapeutics	—
Axil Capital	—	Series A - Red Arrow Therapeutics	—
Axil Capital	—	Series A - Red Arrow Therapeutics	—
Axil Capital	—	Series A - Red Arrow Therapeutics	—
Axil Capital	—	Series A - Red Arrow Therapeutics	—